Author:
Courtet Philippe,Nobile Bénédicte,Lopez-Castroman Jorge
Reference95 articles.
1. Abdallah, C. G., Averill, L. A., & Krystal, J. H. (2015). Ketamine as a promising prototype for a new generation of rapid-acting antidepressants. Annals of the New York Academy of Sciences, 1344(1), 66–77.
2. Al Jurdi, R. K., Swann, A., & Mathew, S. J. (2015). Psychopharmacological agents and suicide risk reduction: Ketamine and other approaches. Current Psychiatry Reports, 17(10), 81.
3. Andrade, C. (2015). Intranasal drug delivery in neuropsychiatry: Focus on intranasal ketamine for refractory depression. The Journal of Clinical Psychiatry, 76(5), 628–631.
4. Arroll, B., Elley, C. R., Fishman, T., Goodyear-Smith, F. A., Kenealy, T., Blashki, G., … MacGillivray, S. (2009). Antidepressants versus placebo for depression in primary care. In Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd. Consulté à l’adresse http://onlinelibrary.wiley.com.gate2.inist.fr/doi/10.1002/14651858.CD007954/abstract .
5. Association, A. P. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). Arlington: American Psychiatric Pub.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献